Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Immunization”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT06397768
What this trial is testing

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV Immunization
Sanofi Pasteur, a Sanofi Company 2,226
Testing effectiveness (Phase 2)WithdrawnNCT03191383
What this trial is testing

Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline
Not applicableActive Not RecruitingNCT07251972
What this trial is testing

Comparison of Two Methods of Immunoprophylaxis Against RSV in Term Newborns

Who this might be right for
Bronchiolitis
Jean-Michel HASCOET 1,050
Not applicableLooking for participantsNCT06172660
What this trial is testing

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

Who this might be right for
RSV Infection
Yale University 3,750
Post-approval studies (Phase 4)Active Not RecruitingNCT06684743
What this trial is testing

Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults

Who this might be right for
RSV
Tor Biering-Sørensen 690,000
Not applicableStudy completedNCT01107535
What this trial is testing

Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus Infection
Abbott 82
Early research (Phase 1)Study completedNCT04354480
What this trial is testing

Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and Older

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 36
Not applicableStudy completedNCT07164430
What this trial is testing

The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Immunization
Nicola Irwin 2,792
Post-approval studies (Phase 4)Study completedNCT06551506
What this trial is testing

The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products

Who this might be right for
Respiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 181
Post-approval studies (Phase 4)Not Yet RecruitingNCT07296120
What this trial is testing

RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients

Who this might be right for
CAR-T Cell TherapyRSV ImmunizationBone Marrow Transplant - Autologous or Allogeneic
The Cooper Health System 30
Not applicableLooking for participantsNCT06881953
What this trial is testing

Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France

Who this might be right for
RSV Infection
Assistance Publique - Hôpitaux de Paris 400
Not applicableUnknownNCT06511687
What this trial is testing

Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL)

Who this might be right for
RSV
Instituto Sistemas Complejos de Ingeniería 160,000
Large-scale testing (Phase 3)Ended earlyNCT06252285
What this trial is testing

Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Who this might be right for
RSV Immunisation
Sanofi Pasteur, a Sanofi Company 6,300
Not applicableStudy completedNCT06185647
What this trial is testing

Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis

Who this might be right for
BronchiolitisRespiratory Syncytial Virus (RSV)Immunization; Infection
Hôpital Armand Trousseau 4,924
Not applicableStudy completedNCT07634692
What this trial is testing

An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the Czechia

Who this might be right for
RSV Immunization
Sanofi 257
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07587801
What this trial is testing

Vaccination Response Modulation With a Targeted Rapamycin Protocol Study

Who this might be right for
Vaccine Immune ResponseHaemodialysis PatientsOlder Adults
Central Adelaide Local Health Network Incorporated 60
Post-approval studies (Phase 4)Study completedNCT05007041
What this trial is testing

Simultaneous RZV and aIIV4 Vaccination

Who this might be right for
PainQuality of LifeInjection Site Reaction+1 more
Duke University 267
Not applicableActive Not RecruitingNCT07122661
What this trial is testing

STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)

Who this might be right for
Respiratory Syncytial Virus (RSV)Respiratory Syncytial VirusLower Respiratory Tract Disease+2 more
Pfizer 1
Post-approval studies (Phase 4)Not Yet RecruitingNCT07693166
What this trial is testing

Study of HIV-Exposed Pregnancies and Transplacental Antibody Delivery Following RSVpreF

Who this might be right for
RSV ImmunizationHIV
University of British Columbia 20
Testing effectiveness (Phase 2)Study completedNCT04752644
What this trial is testing

Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults

Who this might be right for
RSV Infection
Bavarian Nordic 73
Next Page